CONTACT INFORMATION http://www.loyola.org
David W. Hecht
M.D., IDSA
  • Professor
  • Infectious Disease
  • Microbiology and Immunology
Specialties
HIV, General Infectious Disease, AIDS
Board Certifications
  • Infectious Disease - Subspecialty Cert: AM Board of Internal Medicine
  • Internal Medicine - General Cert: AM Board of Internal Medicine
Publications

Kibdelomycin is a potent and selective agent against toxigenic Clostridium difficileMiesel,L.; Hecht,D. W.; Osmolski,J. R.; Gerding,D.; Flattery,A.; Li,F.; Lan,J.; Lipari,P.; Polishook,J. D.; Liang,L.; Liu,J.; Olsen,D. B.; Singh,S. B.Antimicrobial Agents and Chemotherapy 2014 ;58(4):2387-2392

Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006-2009Snydman,D. R.; Jacobus,N. V.; McDermott,L. A.; Golan,Y.; Goldstein,E. J.; Harrell,L.; Jenkins,S.; Newton,D.; Pierson,C.; Rosenblatt,J.; Venezia,R.; Gorbach,S. L.; Queenan,A. M.; Hecht,D. W.Anaerobe 2011 ;17(4):147-151

The novel antibacterial drug XF-70 is a potent inhibitor of Staphylococcus aureus infection of the burn wound.Hurtuk,M. G.; He,L. K.; Szilagyi,A.; Gamelli,R. L.; Hecht,D. W.; Kennedy,R. H.; Rhys-Williams,W.; Love,W. G.; Shankar,R.Journal of Burn Care & Research 2010 ;31(3):462-469

Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007).Snydman,D. R.; Jacobus,N. V.; McDermott,L. A.; Golan,Y.; Hecht,D. W.; Goldstein,E. J.; Harrell,L.; Jenkins,S.; Newton,D.; Pierson,C.; Rihs,J. D.; Yu,V. L.; Venezia,R.; Finegold,S. M.; Rosenblatt,J. E.; Gorbach,S. L.Clinical Infectious Diseases 2010 ;50(Suppl 1):S26-33

Phenotypic and genotypic characterization of tetracycline and minocycline resistance in Clostridium perfringensPark,M.; Rooney,A. P.; Hecht,D. W.; Li,J.; McClane,B. A.; Nayak,R.; Paine,D. D.; Rafii,F.Archives of Microbiology 2010 ;192(10):803-810

Rifaximin Redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment.Johnson,S.; Schriever,C.; Patel,U.; Patel,T.; Hecht,D. W.; Gerding,D. N.Anaerobe 2009 ;15(6):290-291

Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile.O'Connor,J. R.; Galang,M. A.; Sambol,S. P.; Hecht,D. W.; Vedantam,G.; Gerding,D. N.; Johnson,S.Antimicrobial Agents & Chemotherapy 2008 ;52(8):2813-2817

Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea.Sears,C. L.; Islam,S.; Saha,A.; Arjumand,M.; Alam,N. H.; Faruque,A. S.; Salam,M. A.; Shin,J.; Hecht,D.; Weintraub,A.; Sack,R. B.; Qadri,F.Clinical Infectious Diseases 2008 ;47(6):797-803

Interaction of Bacteroides fragilis pLV22a relaxase and transfer DNA with Escherichia coli RP4-TraG coupling protein.Thomas,J.; Hecht,D. W.Molecular microbiology 2007 ;66(4):948-960

In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004.Hecht,D. W.; Galang,M. A.; Sambol,S. P.; Osmolski,J. R.; Johnson,S.; Gerding,D. N.Antimicrobial Agents & Chemotherapy 2007 ;51(8):2716-2719

Characterization of BctA, a mating apparatus protein required for transfer of the Bacteroides fragilis conjugal element BTF-37.Hecht,D. W.; Kos,I. M.; Knopf,S. E.; Vedantam,G.Research in microbiology 2007 ;158(7):600-607

Bacteroides fragilis mobilizable transposon Tn5520 requires a 71 base pair origin of transfer sequence and a single mobilization protein for relaxosome formation during conjugation.Vedantam,G.; Knopf,S.; Hecht,D. W.Molecular microbiology 2006 ;59(1):288-300

Implementing computerized provider order entry with an existing clinical information system.Barron,W. M.; Reed,R. L.; Forsythe,S.; Hecht,D.; Glen,J.; Murphy,B.; Lach,R.; Flores,S.; Tu,J.; Concklin,M.Joint Commission Journal on Quality & Patient Safety 2006 ;32(9):506-516

Information technology. Implementing computerized provider order entry with an existing clinical information systemBarron,W. M.; Reed,R. L.; Forsythe,S.; Hecht,D.; Glen,J.; Murphy,B.; Lach,R.; Flores,S.; Tu,J.; Concklin,M.Joint Commission Journal on Quality & Patient Safety 2006 ;32(9):506-516

Anaerobes: antibiotic resistance, clinical significance, and the role of susceptibility testingHecht,D. W.Anaerobe 2006 ;12(3):115-121

Antibiotics and anaerobes of gut originVedantam,G.; Hecht,D. W.Current opinion in microbiology 2003 ;6(5):457-461

Activities of garenoxacin (BMS-284756) and other agents against anaerobic clinical isolates.Hecht,D. W.; Osmolski,J. R.Antimicrobial Agents & Chemotherapy 2003 ;47(3):910-916

Education
Medical School
  • Loyola University Chicago Stritch School of Medicine
Residency
  • University of Minnesota Hospital and Clinics, Internal Medicine: General
Fellowship
  • Tufts University Affiliated Hospitals, Infectious Diseases